Literature DB >> 26418307

Lead Testing in a Pediatric Population: Underscreening and Problematic Repeated Tests.

Andrew J Knighton1, Nathaniel R Payne, Stuart Speedie.   

Abstract

CONTEXT: Underscreening and problematic repeat lead testing in children.
OBJECTIVE: Identify proportion of underscreening for elevated blood-lead levels in children. For children who receive a lead test, measure the level of problematic repeat lead tests, defined as those with a high probability of not meeting recommended guidelines for lead testing in children measured using a combination of patients' age, test type and sequencing, days between tests, and encounter diagnosis coding.
DESIGN: A population-based retrospective cross-sectional design.
SETTING: All health care services organizations in the state of Minnesota that delivered health services to the defined study population. PARTICIPANTS: The study population was a Medicaid cohort of 12 436 children aged 0 to 18 years observed over a 1-year period. MAIN OUTCOME MEASURES: Proportion of eligible children not receiving at least 1 lead test; proportion of problematic repeat lead tests.
RESULTS: Thirty-five percent of children who should have received at least 1 lead test (n = 1714) during the study period did not. A total of 1856 children had at least 1 lead test and 190 had 2 or more. Fifty percent (50%) of the repeat tests were identified as problematic, representing 5.1% of the lead tests performed. Repeat tests performed in different health systems than the systems where the initial tests were performed had 5.3 times greater odds (adjusted odds ratio: 5.3 [95% confidence interval, 2.8-9.9]) of being problematic.
CONCLUSIONS: The current approach to delivering mandatory lead testing across the state Medicaid population does not ensure that children are appropriately tested and has potential inefficiencies in that testing when it does take place. Use of multiple health care systems is associated with increased potential inefficiencies. Future Medicaid accountable care agreements between the state Medicaid program and participating health systems should emphasize clear population accountability for test screenings to improve patients' safety. A central queryable health resource or health information exchange may enable this.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26418307     DOI: 10.1097/PHH.0000000000000344

Source DB:  PubMed          Journal:  J Public Health Manag Pract        ISSN: 1078-4659


  4 in total

1.  Patterns of Children's Blood Lead Screening and Blood Lead Levels in North Carolina, 2011-2018-Who Is Tested, Who Is Missed?

Authors:  Elizabeth M Kamai; Julie L Daniels; Paul L Delamater; Bruce P Lanphear; Jacqueline MacDonald Gibson; David B Richardson
Journal:  Environ Health Perspect       Date:  2022-06-01       Impact factor: 11.035

2.  More Guidelines than states: variations in U.S. lead screening and management guidance and impacts on shareable CDS development.

Authors:  Jeremy J Michel; Eileen Erinoff; Amy Y Tsou
Journal:  BMC Public Health       Date:  2020-01-29       Impact factor: 3.295

3.  The Shifting Landscape of Lead Exposure: Screening Gaps for Children in North Carolina.

Authors:  Silke Schmidt
Journal:  Environ Health Perspect       Date:  2022-08-03       Impact factor: 11.035

4.  Rural and Urban Ecologies of Early Childhood Toxic Lead Exposure: The State of Kansas, 2005 to 2012.

Authors:  Deniz Yeter; Deena Woodall; Matthew Dietrich; Barbara Polivka
Journal:  Kans J Med       Date:  2022-08-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.